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Ayurveda, the science of life aimed itself in promotion 
and preservation of physical and mental health, has 
provided a special kind of unique field called 
Rasayana. This  is  equally effective in the  prevention 
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of the ill effects of aging and prevention of diseases by 
increasing the immunity and resistance of the 
individual against diseases and its effects are 
attributed to the action of producing the bodily 
tissues of optimum quality. Rasayana must primarily 
be life-sustaining and then tissue building. But the 
tissue building is not possible unless the existing blood 
and tissues are rendered clean and brought to a fit 
condition for fresh growth, and this has also to be 
achieved by the Rasayana. Again, a Rasayana must 
have food-value, in order to be freshly mixed up with 
Rasam (serum) to feed blood and build the several 
tissues in different metabolized stages. The 
reconstruction of the constitution depends upon the 
metabolic process which commences from Rasam. 
Considering all these aspects we have taken 
Ashwagandha and Punarnava compound as Ajasrika 
Rasayana. Ajasrika Rasayana is explained by Dalhana. 
A B S T R A C T  
Background: It has been the desire of mankind to lead a disease free life to its fullest extent. To 
improve quality and quantum of life ‘Rasayana’ has been explained in Ayurveda. It is not only 
indicated in the diseased but also in healthy individuals. Ashwagandha (Withania somnifera Dunal) 
and Punarnava (Boerhavia diffusa Linn) are explained by Vagbhata in Rasayana context. Both these 
can be administered without much restrictions as per Vatatapika mode of administration. Objectives: 
To study the Rasayana effect of Ashwagandha and Punaranava w.r.s. Ajasrika Rasayana. Materials 
and Methods: 32 students who fulfill the inclusion criteria were selected from S.D.M. College of 
Ayurveda, Hassan. They were divided in to two groups. Group A – 16 members were given with 2 
tablets of Harithaki for 3 days for ‘Koshta Shudhi’, followed by a placebo with warm water before 
taking food for 40 days and kept as control. Group B – 16 members were given with 2 tablets of 
Haritaki tablets for ‘Koshta Shudhi’ followed by administration of 12 gm of Ashwagandha and 
Punarnava granules (equal quantity) twice a day along with warm water before taking food for 40 
days. Results: Assessment was done two times in 40 days before and after the administration of 
Ashwapunarnava compound and were assessed for improvement in terms of subjective and objective 
parameters. Observations and results were tabulated and statistically analyzed with relevant 
parameters. Conclusion: Ashwapunarnava compound proved to be cost effective, palatable, safe and 
better drug for daily administration without much restriction. 
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It is a type of Rasayana where Aushadhi are to be 
employed everyday. Under this context Ksheera and 
Ghrita are mentioned[1] in the context of Nitya 
Sevaniya Aharadravya, Amalaki and Triphala 
Rasayana are explained.[2] Ashwagandha (Withania 
somnifera Dunal)[3] and Punarnava (Boerhavia diffusa 
Linn)[4] are explained by Vagbhata in Rasayana 
context. Ashwagandha is explained to possess 
qualities of Pustiprada, Balya, Rasayana and 
Vrishya.[5] Punarnava means that which rejuvenates 
the body on account of Tridoshashamana, Deepana, 
and Rasayana.[6] 
A similar study was conducted with this combination 
in children with beneficiary effects. But in that study 
the drugs were administered with milk as Anupana 
Dravya where the milk itself possesses Rasayana 
properties.[7] In this study the beneficiary effects of 
this compound will be studied in adults with 
Ushnajala as Anupana. The root powders of these 
drugs will be used for the compound. For 
administration the compound will be made in to 
granules form.  
OBJECTIVES 
To study the Rasayana  benefits of Ashwagandha and 
Punarnava and to evaluate benefits of 
Ashwapunarnava compound as a Ajasrika Rasayana. 
MATERIALS AND METHODS 
In this present study the beneficiary effect of 
Ashwapunarnava compound as an AjasrikaRasayana 
was studied by taking 32 subjects over a period of 40 
days. The Apparently healthy  voluntary individuals 
from S.D.M College of Ayurveda, Hassan were 
selected for this study, irrespective of  sex, caste and 
socio economical status. The subjects were examined 
in detail as per special proforma which included both 
Ayurvedic and modern methods of examination. The 
criteria for selection of subjects to this study are as 
follows.  
Criteria for selection of Patients   
Inclusion criteria - Apparently healthy individual 
between 18 to 25 years who are willing to undergo 
trial  and Inmates of  hostels of  SDM college  of  
Ayurveda , Hassan, were included in the study. 
Exclusive criteria - The individual suffering from any 
systemic diseases,Congenital anomalies were 
excluded. 
Laboratory Investigations 
Following laboratory investigations were conducted to 
rule out the pathology and to assess the changes 
during present study,   
▪ Hematological – Hb%, TC, DC, ESR, RBS.  
▪ Serological – Serum proteins, Albumin. 
▪ Urine routine – albumin, sugar and microscopic. 
Research design 
32 apparently healthy subjects who fulfill the inclusion 
criteria were selected from S.D.M. collage of 
Ayurveda, Hassan for the study. They were divided in 
to two groups. 
Group-A (Placebo group) – 16 subjects were given 
with 2 tablets of Harithaki administered for 3 days for 
Koshta Shudhi, followed by a placebo with warm 
water before taking food for 40 days and kept as 
control. 
Group-B (Rasayana group) – 16 members were given 
with 2 tablets of Harithaki for Koshta Shudhi followed 
by administration of 12 gm of Ashwagandha and 
Punarnava granules (equal quantity) twice a day along 
with warm water before taking food for 40 days. 
Assessment criteria 
Assessment of clinical study were done based on the 
subjective and objective changes recorded,  
Subjective parameters 
The beneficiary effects of Rasayana were assessed in 
terms of changes in Arogya Lakshana explained in 
Kashyapa Samhita. The following signs and symptoms 
were graded for assessment.  
Assessment of Arogya Lakshana  
Annabhilasha (Desire for food) 
a) Timely manifestation of hunger - grade 0 
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b) Occasional loss of interest -  grade 1 
c) Disinterested to food always - grade 2 
Bhuktasya Paripaka (Easy digestion of food) 
a) Easy digestion of food -  grade 0 
b) Occasional disturb in digestion - grade 1 
c) Always feel indigestion -  grade 2 
Srustavinmootratwa (Excretion of feces & urine) 
a) Normal -    grade 0 
b) Occasional disturbance -  grade 1 
c) Untimely and disturbed -  grade 2  
 Shareerasya Laghavam (Lighitness of Body) 
a) Feels lightness and enthusiastic - grade 0 
b) Occasional disturbance -  grade 1 
c) Feels heaviness and laziness - grade 2 
Suprasannendriyatwa (Perspicuity of Indriyas) 
a) Natural function of Indriyas - grade 0  
b) Mild improvement -  grade 1 
c) Good improvement  -  grade 2 
Sukhaswapnaprabodanam (Comfortable sleep and 
awakening) 
a) Normal manifestation -  grade 0 
b) Occasional delay -   grade 1 
c) Continuous disturbance -  grade 2 
Bala Labha (Attainment of strength)  
a) Feels healthy and strong -  grade 0 
b) Occasional fluctuation -  grade 1 
c) Always tired and disturbed - grade 2 
Soumanasya (Happiness) 
a) Feels happiness and cheerful - grade 0 
b) Occasional fluctuation -  grade 1 
c) Always depress and disturbed - grade 2 
Objective parameters 
Haemoglobin, Serum protein, Serum Albumin, Body 
Weight, BMI  
OBSERVATIONS AND RESULTS 
The clinical study was conducted on 32 apparently 
healthy subjects who were classified into 2 groups, 16 
subjects in Group - A, Placebo 2 capsules (sugar 
capsule) twice a day with lukewarm water before 
food, and Group- B (Rasayana group) in which 
Ashwapunarnava granules was given in dose of of 12 
gms twice a day with lukewarm water before food 
was administered. 
Age: Age wise distribution of subjects showed that 
maximum 81.25%were in the age group of 18 – 20 yrs, 
followed by 15.65% were in the age group of 21 – 23 
years and 9.37% were in the age group of 24 – 26 
years. 
Sex: Out of 32 subjects of this series 50% were males 
and 50% were female.  
Religion: Religion wise distribution of subjects showed 
that maximum of 87% were Hindus followed by 10 % 
were Muslim and 3% were Christians. 
Socio-Economic Status: Socio-economic status wise 
distribution of subjects showed that maximum of  
89.37% were of belonged to middle class followed by 
0.03% belonged to lower class, 0.06 % belonged to  
upper class. 
Dietary Habit: Analysis of dietary habit of 32 subjects 
of this series showed that 43.75% were vegetarians 
and 56.25% were having mixed dietary habits 
Prakriti: Among the subjects included in the study, 
40.56 % were having Vata-Pittaja and Pitta-Kaphaja 
and 18.75% subjects were of Vata- Kaphaja Prakriti.  
Built: In this series 6.75 % were of large built, 84.37% 
of medium and 0.06 were having       small built. 
Sara: Sara wise distribution of 32 subjects in which 
37.5 % were possessing Rasa Sara, Rakta Sara 31.25 
%, Mamsa Sara 15.62 % and Asthi Sara 15.62%. 
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The clinical study was conducted to understand the 
literary and therapeutic aspects of Ajasrika Rasayana 
and its impact on prevention and promotion of health. 
The role of Aswapunarnava compound as a Ajasrika 
Rasayana which can be taken on daily basis. Under- 
nutrition is one of the risk factor for the varies 
diseases and it is seen more in lower socio economic 
group, where the deficiency of proteins essential 
vitamins and minerals is very common. Deficiencies of 
these nutrients also impair the immunity. In the 
present study statistics shows greater increase of 
serum proteins in the Rasayana group, apart from this 
observation, positive gains are noted in 
anthropometrical assessments also. Hence 
Ashwagandha Punarnava Rasayana can be included 
as an effective nutritional supplementation in 
apparently healthy individual without much 
restriction and without any side effect. 
In Rasayana Group, Annabhilasha was improved by 
68.7 % which was statistically highly significant at 
p<0.001; Placebo therapy improved the Annabhilasha 
by 30 % which was statistical significant at p<0.05. So, 
Rasayana drugs have shown better improvement in 
Annabhilasha in comparison to placebo group in 
subjects involved in this study, in terms of percentage 
and significance.  
In Rasayana Group, Bhuktasya Paripaka was improved 
by 57% which was statistically highly significant at 
p<0.001; where as Placebo therapy improved the by 
66% which was statistical significant at p<0.05. So, 
Rasayana drugs have shown better improvement in 
Bhuktasya Paripaka in comparison to study group in 
subjects involved in this study, in terms of percentage 
and significance.  
In Rasayana Group, Srustavinmootratva was improved 
by 40% which was statistically highly significant at 
p<0.001; where as in, Placebo therapy improved by 
26%, which was statistical significant at p<0.05. So, 
Rasayana drugs have shown better improvement in 
Srustavinmootratva in comparison to placebo group in 
subjects involved in this study, in terms of percentage 
and significance.  
In Rasayana group, Shareerasyalaghavam was 
improved by 61% which was statistically highly 
significant at p<0.001; where as in, Placebo therapy 
improved the by 40% which was statistical significant 
at p<0.001. So, Rasayana drugs have shown better 
improvement in shareerasyalaghavam in comparison 
to placebo group in subjects involved in this study, in 
terms of percentage.  
In Rasayana group, Suprasannendriyatwa was 
improvedby 57.14% which was statistically highly 
significant at p<0.001; where as in, Placebo therapy 
improved the by 11% which was statistical significant 
at p<0.001. So, Rasayana drugs have shown better 
improvement in Suprasannendriyatwa in comparison 
to placebo group in subjects involved in this study, in 
terms of percentage.  
In Rasayana Group, Sukhaswapnaprabodanam was 
improved by 44% which was statistically highly 
significant at p<0.001; where as in, Placebo therapy 
improved the by 8.2% which was statistical significant 
at p<0.001. So, Rasayana drugs have shown better 
improvement in Sukhaswapnaprabodanam in 
comparison to placebogroup in subjects involved in 
this study, in terms of percentage.  
In Rasayana Group, Balalabha was attained by 75% 
which was statistically highly significant at p<0.001; 
where as in, Placebo therapy improved the by 8.2% 
whichwas statistical significant at p<0.001. So, 
Rasayana drugs have shown better improvement in 
Balavalabha in comparison to placebo  group in 
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In Rasayana Group, Soumanasya was improved by 
75% which was statistically highly significant at 
p<0.001; where as in, Placebo therapy improved the 
by 61% which was statistical significant at p<0.001. So, 
Rasayana drugs have shown better improvement in 
Soumanasya in comparison to placebo group in 
subjects involved in this study, in terms of percentage.  
In Rasayana Group, serum protein was improved by 
7.6% which was statistically highly significant at 
p<0.001; where as, Placebo therapy improved the by 
7.2% which was statistical significant at p<0.001. So, 
Rasayana drugs have shown better improvement in 
serum protein in comparison to placebo group in 
subjects involved in this study, in terms of percentage 
and significance.  
In Rasayana Group, serum albumin was improved by 
23% which was statistically highly significant at 
p<0.001; where as, Placebo therapy improved the by 
1.25% whichwas statistical significant at p<0.001. So, 
Rasayana drugs have shown better improvement in 
serum albumin in comparison to placebo group in 
subjects involved in this study, in terms of percentage 
and significance.  
In Rasayana Group, BMI was improved by 6.25% 
which was statistically highly significant at p<0.001; 
where as in Study group, Placebo therapy improved 
the by 1.7% whichwas statistical significant at 
p<0.001. So, Rasayana drugs have shown better 
improvement in BMI in comparison to placebo group 
in subjects involved in this study, in terms of 
percentage and significance.  
CONCLUSION 
Rasayana Chikitsa is explained with a purpose of 
replenishing and nourishing of specific bodily 
elements. Various Rasayana Aushadhis are to be 
administered during various periods of life. In healthy 
persons also Rasayana can be administered without 
much restriction on part of diet and regimen. 
Considering all these aspects scholar has taken 
Ashwagandha and Punarnava compound as an 
Ajasrika Rasayana. Impairment in nutritional status 
(malnutrition) forms an important predisposing factor 
for various diseases. It is necessary to introduce a 
suitable nutritional adjuvinant. Such supplement will 
correct the requirement nutrition and enhance 
Arogya Lakshanas which are told in Ayurveda. 
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